Insider Selling: Advanced Medical Solutions Group (LON:AMS) Insider Sells 18,726 Shares of Stock

Key Points

• Insider Eddie Johnson sold 18,726 shares of Advanced Medical Solutions Group at an average price of GBX 220, totaling around £41,197.20 on October 6th.
• The stock price of Advanced Medical Solutions Group increased by 2.5%, reaching GBX 227, with over 1.2 million shares traded on a day with typical volume of around 816,446.
• Analysts maintain a "Buy" rating for the stock, with a consensus target price between GBX 246 and GBX 300, suggesting potential for upward movement.

Advanced Medical Solutions Group plc (LON:AMS - Get Free Report) insider Eddie Johnson sold 18,726 shares of the stock in a transaction dated Monday, October 6th. The shares were sold at an average price of GBX 220, for a total value of £41,197.20.

Eddie Johnson also recently made the following trade(s):

• On Monday, October 6th, Eddie Johnson acquired 9,040 shares of Advanced Medical Solutions Group stock. The shares were bought at an average cost of GBX 221 per share, for a total transaction of £19,978.40.
• On Monday, October 6th, Eddie Johnson acquired 9,546 shares of Advanced Medical Solutions Group stock. The shares were bought at an average cost of GBX 220 per share, for a total transaction of £21,001.20.

Advanced Medical Solutions Group Stock Up 2.5%

Shares of LON AMS traded up GBX 5.50 during mid-day trading on Wednesday, reaching GBX 227. 1,269,819 shares of the company traded hands, compared to its average volume of 816,446. The company has a debt-to-equity ratio of 37.01, a quick ratio of 4.58 and a current ratio of 8.39. The stock has a market cap of £490.73 million, a PE ratio of 5,443.65, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74. The company's fifty day moving average is GBX 208.68 and its two-hundred day moving average is GBX 204.19. Advanced Medical Solutions Group plc has a fifty-two week low of GBX 168.40 and a fifty-two week high of GBX 242.

Advanced Medical Solutions Group (LON:AMS - Get Free Report) last issued its quarterly earnings data on Wednesday, September 17th. The company reported GBX 5.77 EPS for the quarter. Advanced Medical Solutions Group had a return on equity of 4.57% and a net margin of 8.49%. On average, analysts expect that Advanced Medical Solutions Group plc will post 9.8159509 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts recently commented on the company. Peel Hunt restated a "buy" rating and set a GBX 246 target price on shares of Advanced Medical Solutions Group in a research report on Wednesday, September 17th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a GBX 275 target price on shares of Advanced Medical Solutions Group in a research report on Wednesday, July 16th. Finally, Berenberg Bank restated a "buy" rating and set a GBX 300 target price on shares of Advanced Medical Solutions Group in a research report on Wednesday, September 17th. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company currently has a consensus rating of "Buy" and an average price target of GBX 273.67.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.